Ginkgo Bioworks Holdings, Inc.
- Last sale
- Nov 12, 2026 · -0.39%
- Market cap
- $658.84M
- 64.5M shares
- Filings
- 1,043
Q3 2026−25.1% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
Q3 2026−70.2% FY25 yoy
- $658.84M
- —
- 5.0×
- 1.7×
- -26.34%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $170,155,000 | reported | |
| FY 2024 | 2024-12-31 | $227,043,000 | reported | |
| FY 2023 | 2023-12-31 | $251,455,000 | reported | |
| FY 2022 | 2022-12-31 | $477,706,000 | reported | |
| FY 2021 | 2021-12-31 | $313,837,000 | reported | |
| FY 2020 | 2020-12-31 | $76,657,000 | reported | |
| FY 2019 | 2019-12-31 | $54,184,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $0.00 | $0.00 | — | 50.03M sh | −97.4% | — |
| FY2022 | — | $0.00 | $0.00 | — | 1.89B sh | +17.4% | — |
| FY2021 | — | $25.00M | $25.00M | — | 1.61B sh | +25.1% | — |
| FY2020 | — | $0.00 | $0.00 | — | 1.29B sh | — | — |
| FY2019 | — | $408.00K | $408.00K | — | — | — | — |
Segments
LineFY2025ShareChange
Cell Engineering$132.75M78%−23.7%
Biosecurity———
Total$170.16M
Biological products, except diagnostic substances
Ginkgo Bioworks Holdings, Inc. is the 24th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
IOVAIovance Biotherapeutics, Inc.$263.5M60.6%148.4%$3.5BVXRTVaxart, Inc.$237.3M726.7%6.9%$112.1MRGNXRegenxbio Inc.$170.4M104.5%113.8%$531.0M
DNAGinkgo Bioworks Holdings, Inc. (this company)$170.2M25.1%183.8%$658.8M
BEAMBeam Therapeutics Inc.$139.7M120.0%57.2%$2.5BGLUEMonte Rosa Therapeutics, Inc.$123.7M63.5%31.2%$793.0MATRAAtara Biotherapeutics, Inc.$120.8M6.3%27.1%$80.4MAGENAgenus Inc$114.2M10.4%2.7%$323.1MIBRXImmunityBio, Inc.$113.3M668.3%310.2%$6.5BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Ginkgo Bioworks Holdings, Inc. · CIK 1830214 · Engraved from SEC EDGAR